Sachiko Takemori

Randomized, double-blind, placebo-controlled, parallel-group trial of sirolimus for tocilizumab-resistant idiopathic multicentric Castleman disease

Hiroshi Yamamoto, Toshimasa Shimizu, T. Koga, 2020, Medicine.

An open-label continuation trial of sirolimus for tocilizumab-refractory idiopathic multicentric Castleman disease

Hiroshi Yamamoto, Toshimasa Shimizu, T. Koga, 2020, Medicine.

Retinoic acid receptor stimulation protects midbrain dopaminergic neurons from inflammatory degeneration via BDNF‐mediated signaling

K. Shudo, A. Akaike, Y. Kurauchi, 2009, Journal of neurochemistry.

Retinoic acid receptor stimulation protects midbrain dopaminergic neurons from inflammatory degeneration via BDNF‐mediated signaling

K. Shudo, A. Akaike, Y. Kurauchi, 2009, Journal of neurochemistry.